Alberta Investment Management Corp (AIMCo)’s Soleno Therapeutics SLNO Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,000	Closed	-$837K	–	709
2026 Q1	$837K	Buy	+25,000	New	+$980K	0.01%	425

Alberta Investment Management Corp (AIMCo)'s SLNO Position: Q2 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 25,000 shares — an estimated $837K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $837K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Alberta Investment Management Corp (AIMCo) reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 25,000 Soleno Therapeutics shares in Q2 2026, an estimated $837K.
Alberta Investment Management Corp (AIMCo) first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Alberta Investment Management Corp (AIMCo)'s Soleno Therapeutics position peaked at $837K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2026, filed 6 Aug 2026.